A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
Phase 2
Recruiting
- Conditions
- Squamous Cell Carcinomas of the Head and Neck
- Interventions
- Other: Placebo( Potato starch)Dietary Supplement: Fucoidan
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Target Recruit Count
- 119
- Registration Number
- NCT04597476
- Locations
- π¨π³
National Taiwan University Hospital, Taipei county, Taiwan
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
Not Applicable
Terminated
- Conditions
- Advanced Hepatocellular Carcinoma
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Oligo Fucoidan
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT04066660
- Locations
- π¨π³
Fudan University Zhongshan Hospital, Shanghai, China
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
Not Applicable
Withdrawn
- Conditions
- NSCLC Stage IVNSCLC, Stage III
- Interventions
- Dietary Supplement: Oligo FucoidanDietary Supplement: Placebo
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Registration Number
- NCT03130829
- Locations
- π¨π³
Shuang Ho Hospital, New Taipei City, Taiwan
π¨π³Taipei Medical University Hospital, Taipei, Taiwan
π¨π³Wan-Fang Hospital, Taipei, Taiwan
Β© Copyright 2025. All Rights Reserved by MedPath